Analyst Coverage

Investors

Viking Therapeutics, Inc. is covered by the following analysts:

BMO Capital Markets Matthew Luchini 212-885-4119
B.Riley FBR, Inc.       Mayank Mamtani  646-885-5463
BTIG       Julian Harrison  212-738-6143
Chardan       Michael Morabito, Ph.D.  646-465-9071
H.C. Wainwright & Co.   Joseph Pantginis, Ph.D.          646-975-6968
Laidlaw & Company (UK) Ltd Yale Jen, Ph.D. 212-953-4978
Maxim Group Jason McCarthy, Ph.D.  212-895-3556
Oppenheimer Jay Olson, CFA 212-667-8126
Raymond James Steven Seedhouse, Ph.D. 212-885-1837
Roth Capital Partners Scott Henry, CFA 949-500-0863
Stifel Derek Archila 617-848-2762
SVB Leerink Thomas J. Smith 212-277-6069
Truist Securities Joon Lee, M.D., Ph.D. 212-303-0139
William Blair & Company Andy Hsieh, Ph.D. 312-364-5051

 

 

 

 

 


Please note, that any opinions, estimates or forecasts regarding performance made by these analysts do not represent Viking Therapeutics or its management team. Viking Therapeutics is under no obligation to update this list, thus it may not be complete or up to date.